The FDA has given the green light to a revolutionary HIV drug, stemming from the groundbreaking research of a biochemist at the University of Utah. This approval promises to enhance treatment options and potentially change the game in HIV management. The drug, Lenacapavir, is a testament to the relentless pursuit of science to combat this virus, but it comes at a high price. Here’s what you need to know:

• FDA's approval marks a significant milestone for HIV treatment.
• Lenacapavir could potentially revolutionize the approach to HIV management.
• The drug is based on innovative research from a University of Utah biochemist.
• High costs could be a barrier for many patients.
• Broader implications for future HIV prevention and treatment options are anticipated.

Here's the full scoop.